Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Prev Med Hyg ; 62(3): E621-E624, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1574980

ABSTRACT

Ignác Fülöp Semmelweis (1818-1865) and Florence Nightingale (1820-1910) were two important personalities in the history of medicine and public health. They dealt with the problem of handwashing. Semmelweis is also known as the "father of hand hygiene"; just in 1847 he discovered the etiology and prophylaxis of puerperal sepsis and imposed a new rule mandating handwashing with chlorine for doctors. He also tried to persuade European scientific community of the advantages of handwashing. During the Crimean War, in Scutary (Turkey), Florence Nightingale strengthened handwashing and other hygiene practices in the war hospital where she worked and her handwashing practices reached a reductions in infections. Unfortunately the hygiene practices promoted by Semmelweis and Nightingale were not widely adopted. In general handwashing promotion stood still for over a century. During current pandemic SARS-CoV-2 (COVID-19) one of the most important way to prevent the spread of the virus is still to wash the hands frequently.


Subject(s)
COVID-19 , Puerperal Infection , Female , Hand Disinfection , Humans , Male , Pregnancy , Public Health , Puerperal Infection/prevention & control , SARS-CoV-2
2.
Obstet Gynecol ; 139(1): 3-8, 2022 01 01.
Article in English | MEDLINE | ID: covidwho-1493990

ABSTRACT

Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the United States; specifically, the Pfizer-BioNTech, Moderna, and Johnson & Johnson-Janssen COVID-19 vaccines were granted emergency use authorization by the U.S. Food and Drug Administration in late 2020 and early 2021. Vaccination coverage and intent among adults are lowest among those aged 18-39 years and among females in particular. In females of reproductive age, enthusiasm for receiving a COVID-19 vaccine may be negatively affected by claims currently circulating widely on diverse social media platforms regarding the vaccines adversely affecting fertility and pregnancy. Yet it is important to note that these claims are anecdotal in nature and not supported by the available scientific evidence. It is also imperative that the effects of COVID-19 vaccine on reproductive health are clarified. Herein, we discuss the existing scientific data supporting COVID-19 vaccine safety and efficacy in people who are planning to conceive or who are pregnant or lactating and highlight the importance of COVID-19 vaccination in females of reproductive age.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Preconception Care , Pregnancy Complications, Infectious/prevention & control , Prenatal Care , Puerperal Infection/prevention & control , SARS-CoV-2 , Adolescent , Adult , Female , Humans , Lactation , Pregnancy , Young Adult
3.
Acta Obstet Gynecol Scand ; 99(7): 819-822, 2020 07.
Article in English | MEDLINE | ID: covidwho-1388175

ABSTRACT

The Public Health Agency of Sweden has analyzed how many pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been treated in intensive care units (ICU) in Sweden between 19 March and 20 April 2020 compared with non-pregnant women of similar age. Cases were identified in a special reporting module within the Swedish Intensive Care Registry (SIR). Fifty-three women aged 20-45 years with SARS-CoV-2 were reported in SIR, and 13 of these women were either pregnant or postpartum (<1 week). The results indicate that the risk of being admitted to ICU may be higher in pregnant and postpartum women with laboratory-confirmed SARS-CoV-2 in Sweden, compared with non-pregnant women of similar age.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections , Critical Care , Hospitalization/statistics & numerical data , Pandemics , Pneumonia, Viral , Pregnancy Complications, Infectious , Puerperal Infection , Adult , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Coronavirus Infections/therapy , Critical Care/methods , Critical Care/statistics & numerical data , Female , Humans , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/therapy , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/physiopathology , Pregnancy Complications, Infectious/therapy , Pregnancy Complications, Infectious/virology , Puerperal Infection/epidemiology , Puerperal Infection/physiopathology , Puerperal Infection/therapy , Puerperal Infection/virology , Registries/statistics & numerical data , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Sweden/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL